Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Germany must change its stem cell law to benefit from this innovative technology

This article was originally published in Scrip

Executive Summary

Germany’s insistence on finding a consensus on embryonic stem cell research and its ban on the use of home-grown cell lines are hampering its ability to keep pace with other high- technology countries in this field. The stakes have been raised even higher of late, as US President Barack Obama has reversed the policy of the Bush era, and lifted the ban on stem cell research funding. But the barriers to success for German researchers in this area are simultaneously legal, ethical and religious in nature.



Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts